We are live on ! Find out more
DRIO icon

DarioHealth
DRIO

14 hedge funds and large institutions have $442K invested in DarioHealth in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

654% more capital inflows, than outflows

Capital inflows: $245K | Capital outflows: $32.5K

56% more funds holding

Funds holding: 9 → 14 (+5)

1.09% more ownership

Funds ownership: 1.73% → 2.81% (+1.1%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Anson Funds Management
Anson Funds Management
Texas
+$178K
2
Waters Parkerson & Co
Waters Parkerson & Co
Louisiana
+$33.9K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$25.1K
4
UBS Group
UBS Group
Switzerland
+$6.1K

Top Sellers

Rank Fund Capital Flow
1
Bard Associates
Bard Associates
Illinois
-$26.4K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$6.1K

DRIO Hedge Fund Activity: Q4 2017 in Review

14 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2017, worth a combined $442K — up 45% from $305K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new DRIO positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $178K. The largest seller was Bard Associates, cutting an estimated $26.4K.

  • 14 institutional investors held DarioHealth (DRIO) as of Q4 2017, up from 9 in Q3 2017.
  • Funds reported $442K of DarioHealth stock for Q4 2017, up 45% quarter-over-quarter.
  • 5 funds opened new DarioHealth positions in Q4 2017 and 0 closed out, a net change of +5 holders.
  • The largest DarioHealth buyer in Q4 2017 was Anson Funds Management, an estimated $178K added.
  • The largest DarioHealth seller in Q4 2017 was Bard Associates, an estimated $26.4K sold.

Based on aggregated 13F filings for Q4 2017.